Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Shapiro

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Ophthalmology|February 7, 2012
Bevacizumab for ROPMichael Blair, Michael J Shapiro
The Journal of Organic Chemistry|October 18, 1996
Mixture Analysis in Combinatorial Chemistry. Application of Diffusion-Resolved NMR SpectroscopyMengfen Lin, Michael J. Shapiro
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2008
Detection of facial hypotonia and diagnosis of facioscapulohumeral dystrophyVeeral S Sheth, Michael J Shapiro
JAMA Ophthalmology|April 13, 2013
In reply to Mireskandari and coworkersMichael P Blair, Michael J Shapiro
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 14, 2007
Osteoporosis-pseudoglioma syndrome may not be caused by persistent fetal vasculatureMichael P Blair, Michael J Shapiro
Annual Review of Immunology|January 29, 2020
Chromatin-Modifying Enzymes in T Cell DevelopmentMichael J Shapiro, Virginia Smith Shapiro
Cytokine|December 18, 2010
Transcriptional repressors, corepressors and chromatin modifying enzymes in T cell developmentMichael J Shapiro, Virginia Smith Shapiro
Ophthalmology|September 24, 2017
Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844)Michael P Blair, Michael J Shapiro,
Current Opinion in Chemical Biology|June 1, 2005
Fragonomics: fragment-based drug discoveryEdward R Zartler, Michael J Shapiro
ACS Medicinal Chemistry Letters|October 15, 2014
EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic PeptidesGilles H Goetz, Laurence Philippe, Michael J Shapiro
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Ophthalmology|February 7, 2012
Bevacizumab for ROPMichael Blair, Michael J Shapiro
The Journal of Organic Chemistry|October 18, 1996
Mixture Analysis in Combinatorial Chemistry. Application of Diffusion-Resolved NMR SpectroscopyMengfen Lin, Michael J. Shapiro
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2008
Detection of facial hypotonia and diagnosis of facioscapulohumeral dystrophyVeeral S Sheth, Michael J Shapiro
JAMA Ophthalmology|April 13, 2013
In reply to Mireskandari and coworkersMichael P Blair, Michael J Shapiro
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 14, 2007
Osteoporosis-pseudoglioma syndrome may not be caused by persistent fetal vasculatureMichael P Blair, Michael J Shapiro
Annual Review of Immunology|January 29, 2020
Chromatin-Modifying Enzymes in T Cell DevelopmentMichael J Shapiro, Virginia Smith Shapiro
Cytokine|December 18, 2010
Transcriptional repressors, corepressors and chromatin modifying enzymes in T cell developmentMichael J Shapiro, Virginia Smith Shapiro
Ophthalmology|September 24, 2017
Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844)Michael P Blair, Michael J Shapiro,
Current Opinion in Chemical Biology|June 1, 2005
Fragonomics: fragment-based drug discoveryEdward R Zartler, Michael J Shapiro
ACS Medicinal Chemistry Letters|October 15, 2014
EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic PeptidesGilles H Goetz, Laurence Philippe, Michael J Shapiro
Pageof 12